A successful effort to improve adherence to treatment guidelines for bipolar disorder.
New York State Psychiatric Institute, 1051 Riverside Dr., Unit 14, New York, NY 10032, USA. smithto@pi.cpmc.columbia.edu
Thomas E
TE
Smith
Stewart B
SB
Levine
Judith
J
Hampel
D000208:Acute Disease; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005500:Follow-Up Studies; D019983:Guideline Adherence; D006760:Hospitalization; D006801:Humans; D007318:Inservice Training; D017410:Practice Guidelines as Topic; D015397:Program Evaluation; D011570:Psychiatry; D011785:Quality Assurance, Health Care
D000927:Anticonvulsants; D018692:Antimanic Agents; D014150:Antipsychotic Agents